These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 20594590)

  • 1. Intensive treatment of hyperglycaemia: ACCORD.
    Klein R
    Lancet; 2010 Aug; 376(9739):391-2. PubMed ID: 20594590
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intensive glycemia control of type-2 diabetes mellitus: a real A(D)VANCe or a deep dis(ACCORD)?].
    Lambiel J; Fumeaux T
    Rev Med Suisse; 2008 Aug; 4(166):1734. PubMed ID: 18777740
    [No Abstract]   [Full Text] [Related]  

  • 3. [Intensive glucose control in type 2 diabetes is beneficial].
    Nilsson PM; Attvall S
    Lakartidningen; 2009 Sep 2-8; 106(36):2198. PubMed ID: 19817174
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.
    Ismail-Beigi F; Craven T; Banerji MA; Basile J; Calles J; Cohen RM; Cuddihy R; Cushman WC; Genuth S; Grimm RH; Hamilton BP; Hoogwerf B; Karl D; Katz L; Krikorian A; O'Connor P; Pop-Busui R; Schubart U; Simmons D; Taylor H; Thomas A; Weiss D; Hramiak I;
    Lancet; 2010 Aug; 376(9739):419-30. PubMed ID: 20594588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive treatment of hyperglycaemia: what are the objectives?
    Yudkin JS; Richter B; Gale EA
    Lancet; 2010 Oct; 376(9751):1462-3. PubMed ID: 21036266
    [No Abstract]   [Full Text] [Related]  

  • 6. Postprandial hyperglycaemia--its importance and implications.
    Lüddeke HJ
    Int J Clin Pract Suppl; 1999 Jul; 104():3-7; discussion 18-20. PubMed ID: 12669731
    [No Abstract]   [Full Text] [Related]  

  • 7. [Intensive blood sugar treatment in type 2 diabetics: no evidence for increased mortality in the ADVANCE study compared with ACCORD study].
    Füchtenbusch M; Hummel M
    MMW Fortschr Med; 2008 Apr; 150(17):42-4. PubMed ID: 18510157
    [No Abstract]   [Full Text] [Related]  

  • 8. [Intensive glucose control in type 2 diabetes. The benefit greater than the risks?].
    Rydén M; Freyschuss B
    Lakartidningen; 2008 Oct 15-21; 105(42):2910-1. PubMed ID: 19025147
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination therapy with multiple oral hypoglycaemic agents together with short-term basal insulin in new-onset Type 2 diabetes mellitus with marked hyperglycaemia.
    Ray S; Mukherjee JJ
    Diabet Med; 2017 Sep; 34(9):1322-1323. PubMed ID: 28586518
    [No Abstract]   [Full Text] [Related]  

  • 10. [Correlation of glycosylated serum protein and glycosylated hemoglobin in patients with diabetes mellitus type 2 at various stages of metabolic compensation].
    Plechanow J; Bartosiewicz W; Szczepanik Z
    Pol Arch Med Wewn; 1987 Sep; 78(3):149-53. PubMed ID: 3271294
    [No Abstract]   [Full Text] [Related]  

  • 11. Diabetes specialists keep ACCORD data in perspective.
    Traynor K
    Am J Health Syst Pharm; 2008 Mar; 65(6):488, 490. PubMed ID: 18319488
    [No Abstract]   [Full Text] [Related]  

  • 12. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
    ; Patel A; MacMahon S; Chalmers J; Neal B; Billot L; Woodward M; Marre M; Cooper M; Glasziou P; Grobbee D; Hamet P; Harrap S; Heller S; Liu L; Mancia G; Mogensen CE; Pan C; Poulter N; Rodgers A; Williams B; Bompoint S; de Galan BE; Joshi R; Travert F
    N Engl J Med; 2008 Jun; 358(24):2560-72. PubMed ID: 18539916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of glycemic control.
    Shahady EJ
    J Fam Pract; 2011 Sep; 60(9 Suppl):S4-6. PubMed ID: 21912776
    [No Abstract]   [Full Text] [Related]  

  • 14. Moving beyond HbA1c and plasma glucose levels to understand glycemic status in type 2 diabetes mellitus.
    Vijayakumar V; Mavathur R; Aruchunan M; Nandi Krishnamurthy M
    J Diabetes; 2018 Jul; 10(7):609-610. PubMed ID: 29437298
    [No Abstract]   [Full Text] [Related]  

  • 15. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
    Lancet; 1998 Sep; 352(9131):837-53. PubMed ID: 9742976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comments on the AACE/ACE statement on glycemic control for patients with type 2 diabetes mellitus.
    Eledrisi M
    Endocr Pract; 2010; 16(1):130-1; author reply 131-2. PubMed ID: 20146995
    [No Abstract]   [Full Text] [Related]  

  • 17. Should we use intensive insulin therapy after oral agent failure in type II diabetes?
    Colwell JA
    Diabetes Care; 1996 Aug; 19(8):896-8. PubMed ID: 8842613
    [No Abstract]   [Full Text] [Related]  

  • 18. Diabetes. Paradoxical effects of tightly controlled blood sugar.
    Taubes G
    Science; 2008 Oct; 322(5900):365-7. PubMed ID: 18927369
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety of very tight glucose control in type 2 diabetes in question.
    Idris I
    Diabetes Obes Metab; 2008 May; 10(5):438. PubMed ID: 18431839
    [No Abstract]   [Full Text] [Related]  

  • 20. Glycemic targets and cardiovascular disease.
    Cefalu WT
    N Engl J Med; 2008 Jun; 358(24):2633-5. PubMed ID: 18539919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.